Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Yu Liu

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Medicina (Kaunas, Lithuania)|February 27, 2026
Strategies for Preventing Nosocomial Influenza in Acute-Care Hospitals: A Narrative ReviewWei-Hsuan Huang, Yi-Fang Ho, Jia-Jen Jang, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
Gut|November 1, 2018
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free miceWei-Kai Wu, Chieh-Chang Chen, Po-Yu Liu, et al.
Microbiome|November 20, 2020
Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discoveryWei-Kai Wu, Suraphan Panyod, Po-Yu Liu, et al.
NPJ Biofilms and Microbiomes|January 28, 2022
Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulationSuraphan Panyod, Wei-Kai Wu, Pei-Chen Chen, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
Biomedical Journal|June 22, 2020
Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of TaiwanShiu-Feng Huang, Yhu-Chering Huang, Feng-Yee Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Po-Yu Liu, Yu-Lin Lee, Min-Chi Lu, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Medicina (Kaunas, Lithuania)|February 27, 2026
Strategies for Preventing Nosocomial Influenza in Acute-Care Hospitals: A Narrative ReviewWei-Hsuan Huang, Yi-Fang Ho, Jia-Jen Jang, et al.
Infectious Diseases and Therapy|May 21, 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, et al.
Gut|November 1, 2018
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free miceWei-Kai Wu, Chieh-Chang Chen, Po-Yu Liu, et al.
Microbiome|November 20, 2020
Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discoveryWei-Kai Wu, Suraphan Panyod, Po-Yu Liu, et al.
NPJ Biofilms and Microbiomes|January 28, 2022
Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulationSuraphan Panyod, Wei-Kai Wu, Pei-Chen Chen, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
Biomedical Journal|June 22, 2020
Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of TaiwanShiu-Feng Huang, Yhu-Chering Huang, Feng-Yee Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Po-Yu Liu, Yu-Lin Lee, Min-Chi Lu, et al.
Pageof 18